The article reports on a clinical study showing that duodenal mucosal resurfacing helps reduce weight regain after stopping GLP-1 medications like Ozempic or Wegovy. The primary focus is on the procedure’s effectiveness in maintaining weight loss post-drug discontinuation, based on a randomized, sham-controlled trial. Key facts to include: – Primary entity: duodenal mucosal resurfacing (the procedure) – Action: reduces or prevents weight regain – Context: after stopping Ozempic/Wegovy (or GLP-1 agonists like tirzepatide) – Evidence: from a blinded, randomized, sham-controlled trial presented at DDW 2026 – Outcome: significantly less weight regain in treatment group vs. sham We must front-load the primary entity (duodenal mucosal resurfacing), use a strong precise verb (e.g., reduces, prevents, cuts, slashes), avoid fluff, stay under 80 characters, and be strictly factual. Evaluating options: “Duodenal Mucosal Resurfacing Reduces Weight Regain After Stopping Ozempic” – Character count: 64 – Front-loads procedure – Uses strong verb “Reduces” – Accurately reflects core finding: less weight regain in treatment group – Mentions Ozempic as representative GLP-1 (article uses Ozempic/Wegovy/tirzepatide interchangeably in context) – No forbidden words, no clickbait, no colon, no quotes – Specific and factual Alternative: “Duodenal Mucosal Resurfacing Cuts Weight Regain Post-GLP-1 Therapy” – “Cuts” is strong, but “Post-GLP-1 Therapy” is slightly less precise than “After Stopping Ozempic” since the article emphasizes stopping the drug, and Ozempic is named in the source title and article as a familiar reference. – Character count: 58 — shorter, but “Ozempic” is more recognizable to general searchers than “GLP-1 Therapy” for SEO. – However, the article does mention tirzepatide (active ingredient in Zepbound, not Ozempic/Wegovy which are semaglutide). But the article says: “participants who had lost weight using medications like Ozempic or Wegovy” and “stopping tirzepatide”